Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Drug Quality and Security Act
Client: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Firm: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, and implementation of the Drug Quality and Security Act. Contact concerning HRSA oversight of 340B drug discount program. Contact concerning the Drug Quality and Security Act, H.R. 3204, all titles. Communication with the FDA on the labeling of generic medications and biosimilars. Communication with FTC on biosimilars.
Drug Quality and Security Act
Client: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Firm: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS via AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
2014 · third_quarter · Q3
Communication with Centers for Medicare and Medicaid Services regarding Innovation Center, direct reimbursement under Medicare Program, and annual payment updates. Support for HR 4190, a bill that would amend Title 18 of the Social Security Act to provide for coverage under the Medicare Program of pharmacist services.
Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, and implementation of the Drug Quality and Security Act. Contact concerning HRSA oversight of 340B drug discount program. Contact concerning the Drug Quality and Security Act, H.R. 3204, all titles. Communication with the FDA on the labeling of generic medications and biosimilars. Communication with FTC on biosimilars.
Source: Senate LDA
Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, and implementation of the Drug Quality and Security Act. Contact concerning HRSA oversight of 340B drug discount program. Communication with the OIG on Compendia . Contact concerning the Drug Quality and Security Act, H.R. 3204, all titles. Communication with the FDA on labeling of generic medications and drugs containing salts. Communication with FTC on biosimilars. Support for H.R. 3742, all titles, theAntibiotic Development to Advance Patient Treatment Act.
Antibiotic Development to Advance Patient Treatment Act of 2013
Client: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Firm: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, and implementation of the Drug Quality and Security Act. Contact concerning HRSA oversight of 340B drug discount program. Communication with the OIG on Compendia . Contact concerning the Drug Quality and Security Act, H.R. 3204, all titles. Communication with the FDA on labeling of generic medications and drugs containing salts. Communication with FTC on biosimilars. Support for H.R. 3742, all titles, theAntibiotic Development to Advance Patient Treatment Act.
To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Client: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Firm: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
Communication with Centers for Medicare and Medicaid Services regarding Innovation Center, direct reimbursement under Medicare Program, and annual payment updates. Support for HR 4190, a bill that would amend Title 18 of the Social Security Act to provide for coverage under the Medicare Program of pharmacist services.
To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Client: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Firm: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
Communication with Centers for Medicare and Medicaid Services regarding Innovation Center, direct reimbursement under Medicare Program, and annual payment updates. Support for HR 4190, a bill that would amend Title 18 of the Social Security Act to provide for coverage under the Medicare Program of pharmacist services.
Labor-Health and Human Services Appropriations seeking Food and Drug Administration funding.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS via AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
2014 · second_quarter · Q2
Labor-Health and Human Services Appropriations seeking Food and Drug Administration funding.
Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, and implementation of the Drug Quality and Security Act. Contact concerning HRSA oversight of 340B drug discount program. Communication with the OIG on Compendia . Contact concerning the Drug Quality and Security Act, H.R. 3204, all titles. Communication with the FDA on labeling of generic medications and drugs containing salts. Communication with FTC on biosimilars. Support for H.R. 3742, all titles, theAntibiotic Development to Advance Patient Treatment Act.
Communication with Centers for Medicare and Medicaid Services regarding Innovation Center, direct reimbursement under Medicare Program, and annual payment updates. Support for HR 4190, a bill that would amend Title 18 of the Social Security Act to provide for coverage under the Medicare Program of pharmacist services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE